Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis

Medical Physics

Volumn 41, Issue 7, 2014, Pages

  Martin, Peter R ^a   Cool, Derek W ^a,b   Romagnoli, Cesare ^a   Fenster, Aaron ^a,b   Ward, Aaron D ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

3D guided biopsy planning; 3D tumor shape; 3D ultrasound; needle guidance error; prostate cancer diagnosis

Indexed keywords

BINARY IMAGES; BIOPSY; CORE SAMPLES; DISEASES; ERRORS; IMAGE ENHANCEMENT; IMAGE REGISTRATION; INFORMATION ANALYSIS; ITERATIVE METHODS; MAGNETIC RESONANCE IMAGING; MEAN SQUARE ERROR; NEEDLES; PROBABILITY; SPHERES; ULTRASONICS; UROLOGY;

3-D ULTRASOUND; DYNAMIC CONTRAST ENHANCED; ITERATIVE CLOSEST POINTS; MINIMIZING THE NUMBER OF; NEEDLE GUIDANCE; PROSTATE CANCERS; ROOT MEAN SQUARED ERRORS; TUMOR SHAPE;

TUMORS;

ADULT; AGED; ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; DIAGNOSTIC ERROR; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE GUIDED BIOPSY; MALE; MEDICAL ERROR; NEEDLE DELIVERY ERROR; NUCLEAR MAGNETIC RESONANCE IMAGING; PROBABILITY; PROSTATE CANCER; RETROSPECTIVE STUDY; SAMPLING; THREE DIMENSIONAL IMAGING; TRANSRECTAL ULTRASONOGRAPHY; TUMOR VOLUME; DIFFUSION WEIGHTED IMAGING; ECHOGRAPHY; IMAGE PROCESSING; LABORATORY DIAGNOSIS; MIDDLE AGED; NEEDLE BIOPSY; NORMAL DISTRIBUTION; PATHOLOGY; PROCEDURES; PROSTATE; PROSTATIC NEOPLASMS; RECTUM; UNCERTAINTY;

BIOPSY, NEEDLE; DIFFUSION MAGNETIC RESONANCE IMAGING; FALSE NEGATIVE REACTIONS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGE-GUIDED BIOPSY; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NORMAL DISTRIBUTION; PROBABILITY; PROSTATE; PROSTATIC NEOPLASMS; RECTUM; RETROSPECTIVE STUDIES; TUMOR BURDEN; UNCERTAINTY;

EID: 84903286863     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.4883838     Document Type: Article

References (38)

1. Canadian Cancer Statistics (Canadian Cancer Society, Toronto, Canada, 2013).
2. R. Siegel et al., " Cancer Statistics, 2012," CA: Cancer J. Clin. 62, 10-29 (2012). 10.3322/caac.20138
3. D. F. Gleason, " Classification of prostatic carcinomas," Cancer Chemother. Rep. 50 (3), 125-128 (1966).
4. M. E. Chen, P. Troncoso, D. A. Johnston, K. Tang, and R. J. Babaian, " Optimization of prostate biopsy strategy using computer based analysis," J. Urol. 158 (6), 2168-2175 (1997). 10.1016/S0022-5347(01)68188- 6 (Pubitemid 27481351)
5. D. Shen, Z. Lao, J. Zeng, W. Zhang, I. A. Sesterhenn, L. Sun, J. W. Moul, E. H. Herskovits, G. Fichtinger, and C. Davatzikos, " Optimized prostate biopsy via a statistical atlas of cancer spatial distribution," Med. Image Anal. 8 (2), 139-150 (2004). 10.1016/j.media.2003.11.002 (Pubitemid 38444062)
6. F. Rabbani, N. Stroumbakis, B. R. Kava, M. S. Cookson, and W. R. Fair, " Incidence and clinical significance of false-negative sextant prostate biopsies," J. Urol. 159 (4), 1247-1250 (1998). 10.1016/S0022-5347(01)63574- 2 (Pubitemid 28172807)
7. A. Rajinikanth, M. Manoharan, C. T. Soloway, F. J. Civantos, and M. S. Soloway, " Trends in Gleason score, concordance between biopsy and prostatectomy over 15 years," Urology 72 (1), 177-182 (2008). 10.1016/j.urology.2007.10.022
8. J. J. Futterer, S. W. Heijmink, T. W. Scheenen, J. Veltman, H. J. Huisman, P. Vos, C. A. Hulsbergen-Van de Kaa, J. A. Witjes, P. F. Krabbe, A. Heerschap, and J. O. Barentsz, " Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging," Radiology 241 (2), 449-458 (2006). 10.1148/radiol.2412051866 (Pubitemid 44632891)
9. A. V. D'Amico, C. M. Tempany, R. Cormack, N. Hata, M. Jinzaki, K. Tuncali, M. Weinstein, and J. P. Richie, " Transperineal magnetic resonance image guided prostate biopsy," J. Urol. 164 (2), 385-387 (2000). 10.1016/S0022-5347(05)67366-1 (Pubitemid 30481931)
10. P. Blumenfeld, N. Hata, S. DiMaio, K. Zou, S. Haker, G. Fichtinger, and C. M. Tempany, " Transperineal prostate biopsy under magnetic resonance image guidance: A needle placement accuracy study," J. Magn. Reson. Imaging 26 (3), 688-694 (2007). 10.1002/jmri.21067 (Pubitemid 350194593)
11. J. Cepek, B. A. Chronik, U. Lindner, J. Trachtenberg, S. R. Davidson, J. Bax, and A. Fenster, " A system for MRI-guided transperineal delivery of needles to the prostate for focal therapy," Med. Phys. 40 (1), 012304 (15pp.) (2013). 10.1118/1.4773043
12. A. Krieger, C. Csoma, Iordachital II, P. Guion, A. K. Singh, G. Fichtinger, and L. L. Whitcomb, " Design and preliminary accuracy studies of an MRI-guided transrectal prostate intervention system," Med. Image Comput. Comput. Assist. Interv. 4792, 59-67 (2007). 10.1007/978-3-540-75759-7-8
13. N. Hata, M. Jinzaki, D. Kacher, R. Cormak, D. Gering, A. Nabavi, S. G. Silverman, A. V. D'Amico, R. Kikinis, F. A. Jolesz, and C. M. Tempany, " MR imaging-guided prostate biopsy with surgical navigation software: Device validation and feasibility," Radiology 220 (1), 263-268 (2001). 10.1148/radiology.220.1.r01jl44263 (Pubitemid 32577996)
14. J. O. Barentsz, J. Richenberg, R. Clements, P. Choyke, S. Verma, G. Villeirs, O. Rouviere, V. Logager, J. J. Futterer, and R. European Society of Urogenital, " ESUR prostate MR guidelines 2012," Eur. Radiol. 22 (4), 746-757 (2012). 10.1007/s00330-011-2377-y
15. A. Sciarra, J. Barentsz, A. Bjartell, J. Eastham, H. Hricak, V. Panebianco, and J. A. Witjes, " Advances in magnetic resonance imaging: How they are changing the management of prostate cancer," Eur. Urol. 59 (6), 962-977 (2011). 10.1016/j.eururo.2011.02.034
16. M. R. Engelbrecht, J. O. Barentsz, G. J. Jager, M. van der Graaf, A. Heerschap, J. P. Sedelaar, R. G. Aarnink, and J. J. de la Rosette, " Prostate cancer staging using imaging," BJU Int. 86 (Suppl 1), 123-134 (2000). 10.1046/j.1464-410X.2000.00592.x (Pubitemid 30453646)
17. I. Ocak, M. Bernardo, G. Metzger, T. Barrett, P. Pinto, P. S. Albert, and P. L. Choyke, " Dynamic contrast-enhanced MRI of prostate cancer at 3 T: A study of pharmacokinetic parameters," AJR, Am. J. Roentgenol. 189 (4), W192-W201 (2007). 10.2214/AJR.06.1329
18. H. A. Vargas, O. Akin, T. Franiel, Y. Mazaheri, J. Zheng, C. Moskowitz, K. Udo, J. Eastham, and H. Hricak, " Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer, tumor detection and assessment of aggressiveness," Radiology 259 (3), 775-784 (2011). 10.1148/radiol.11102066
19. B. Turkbey, V. P. Shah, Y. Pang, M. Bernardo, S. Xu, J. Kruecker, J. Locklin, A. A. Baccala Jr., A. R. Rastinehad, M. J. Merino, J. H. Shih, B. J. Wood, P. A. Pinto, and P. L. Choyke, " Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?," Radiology 258 (2), 488-495 (2011). 10.1148/radiol.10100667
20. Y. Itou, K. Nakanishi, Y. Narumi, Y. Nishizawa, and H. Tsukuma, " Clinical utility of apparent diffusion coefficient (ADC) values in patients with prostate cancer: Can ADC values contribute to assess the aggressiveness of prostate cancer?," J. Magn. Reson. Imaging 33 (1), 167-172 (2011). 10.1002/jmri.22317
21. T. Hambrock, D. M. Somford, H. J. Huisman, I. M. van Oort, J. A. Witjes, C. A. Hulsbergen-van de Kaa, T. Scheenen, and J. O. Barentsz, " Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer," Radiology 259 (2), 453-461 (2011). 10.1148/radiol.11091409
22. J. Bax, D. Cool, L. Gardi, K. Knight, D. Smith, J. Montreuil, S. Sherebrin, C. Romagnoli, and A. Fenster, " Mechanically assisted 3D ultrasound guided prostate biopsy system," Med. Phys. 35 (12), 5397-5410 (2008). 10.1118/1.3002415
23. Y. Sun et al., " Efficient convex optimization approach to 3D non-rigid MR-TRUS registration," in MICCAI Proceedings, Nagoya, Japan, 2013.
24. M. Baumann, P. Mozer, V. Daanen, and J. Troccaz, " Prostate biopsy tracking with deformation estimation," Med. Image Anal. 16 (3), 562-576 (2012). 10.1016/j.media.2011.01.008
25. S. Xu, J. Kruecker, B. Turkbey, N. Glossop, A. K. Singh, P. Choyke, P. Pinto, and B. J. Wood, " Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies," Comput. Aided Surg. 13 (5), 255-264 (2008). 10.3109/10929080802364645
26. B. A. Hadaschik, T. H. Kuru, C. Tulea, P. Rieker, I. V. Popeneciu, T. Simpfendorfer, J. Huber, P. Zogal, D. Teber, S. Pahernik, M. Roethke, P. Zamecnik, W. Roth, G. Sakas, H. P. Schlemmer, and M. Hohenfellner, " A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion," J. Urol. 186 (6), 2214-2220 (2011). 10.1016/j.juro.2011.07.102
27. D. W. Cool et al., " Fusion of MRI to 3D TRUS for mechanically-assisted targeted prostate biopsy: System design and initial clinical experience," Lect. Notes Comput. Sci. 6963, 121-133 (2011). 10.1007/978-3-642-23944-1
28. W. J. van de Ven, C. A. Hulsbergen-van de Kaa, T. Hambrock, J. O. Barentsz, and H. J. Huisman, " Simulated required accuracy of image registration tools for targeting high-grade cancer components with prostate biopsies," Eur. Radiol. 23 (5), 1401-1407 (2013). 10.1007/s00330-012-2701-1
29. L. E. Quint, J. S. Van Erp, P. H. Bland, S. H. Mandell, E. A. Del Buono, H. B. Grossman, G. M. Glazer, and P. W. Gikas, " Carcinoma of the prostate: MR images obtained with body coils do not accurately reflect tumor volume," AJR, Am. J. Roentgenol. 156 (3), 511-516 (1991). 10.2214/ajr.156.3.1899746
30. P. J. Besl and N. D. Mckay, " A method for registration of 3-D shapes," IEEE Trans. Pattern Anal. Mach. Intell. 14 (2), 239-256 (1992). 10.1109/34.121791
31. Y. Hu, H. U. Ahmed, Z. Taylor, C. Allen, M. Emberton, D. Hawkes, and D. Barratt, " MR to ultrasound registration for image-guided prostate interventions," Med. Image Anal. 16 (3), 687-703 (2012). 10.1016/j.media.2010.11.003
32. J. I. Epstein, " Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens," J. Urol. 186 (3), 790-797 (2011). 10.1016/j.juro.2011.02.2695
33. V. V. Karnik, A. Fenster, J. Bax, C. Romagnoli, and A. D. Ward, " Evaluation of intersession 3D-TRUS to 3D-TRUS image registration for repeat prostate biopsies," Med. Phys. 38 (4), 1832-1843 (2011). 10.1118/1.3560883
34. T. De Silva, A. Fenster, D. W. Cool, L. Gardi, C. Romagnoli, J. Samarabandu, and A. D. Ward, " 2D-3D rigid registration to compensate for prostate motion during 3D TRUS-guided biopsy," Med. Phys. 40 (2), 022904 (1pp.) (2013). 10.1118/1.4773873
35. J. I. Epstein, P. C. Walsh, M. Carmichael, and C. B. Brendler, " Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer," JAMA 271 (5), 368-374 (1994). 10.1001/jama.1994. 03510290050036 (Pubitemid 24037911)
36. C. M. Hoeks, M. G. Schouten, J. G. Bomers, S. P. Hoogendoorn, C. A. Hulsbergen-van de Kaa, T. Hambrock, H. Vergunst, J. P. Sedelaar, J. J. Futterer, and J. O. Barentsz, " Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: Detection of clinically significant prostate cancers," Eur. Urol. 62 (5), 902-909 (2012). 10.1016/j.eururo.2012.01.047
37. A. G. Anastasiadis, M. P. Lichy, U. Nagele, M. A. Kuczyk, A. S. Merseburger, J. Hennenlotter, S. Corvin, K. D. Sievert, C. D. Claussen, A. Stenzl, and H. P. Schlemmer, " MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies," Eur. Urol. 50 (4), 738-748; 748-749 (2006) (discussion). 10.1016/j.eururo.2006.03.007 (Pubitemid 44332667)
38. T. Hambrock, C. Hoeks, C. Hulsbergen-van de Kaa, T. Scheenen, J. Futterer, S. Bouwense, I. van Oort, F. Schroder, H. Huisman, and J. Barentsz, " Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort," Eur. Urol. 61 (1), 177-184 (2012). 10.1016/j.eururo.2011.08.042